Drug Pipeline

Sirolimus Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
75
Active Studies
33
Recruiting
5
Phase 3
10
Top Sponsors
8
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody…
Recruitment opened
2026-06-05 NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody…
date change Primary completion pushed: 2029-05-01 -> 2029-06-01
2026-06-05 NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody…
date change Completion pushed: 2029-09-01 -> 2029-10-01
2026-06-05 NCT06872333
Allo HSCT for High Risk Hemoglobinopathies
Trial arms changed: 4 -> 5
2026-05-23 NCT06752694
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell…
overall status: "Recruiting" → "Active Not Recruiting"
2026-05-23 NCT06752694
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell…
Enrollment reduced: 20 -> 1 participants
2026-05-23 NCT06752694
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell…
date change Primary completion moved earlier: 2027-12-31 -> 2026-01-23
2026-05-23 NCT06752694
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell…
date change Completion moved earlier: 2027-12-31 -> 2026-10-15
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-08 NCT07634120 Vertebrobasilar Dolichoectasia Treatment With Sirolimus Phase 2 Not Yet Recruiting
2026-06-01 NCT07616154 Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease Phase 2 Not Yet Recruiting
2026-05-14 NCT07587801 Vaccination Response Modulation With a Targeted Rapamycin Protocol Study Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 4
3
Phase 3
4
Phase 2/3
1
Phase 2
32
Phase 1/2
20
Phase 1
11
Early Phase 1
3
Not specified
1
Active Trials — top 25 of 75
NCT IDTitleConditionStatus
Phase 4
NCT05193565 Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in… Kidney Transplantation Active, Not Recruiting
NCT07426484 Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy Cutaneous Squamous Cell Carcinoma Not Yet Recruiting
NCT07542314 Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne… Duchenne Muscular Dystrophy Not Yet Recruiting
Phase 3
NCT07378657 Systematic Approach for Children With Orbital Malformation With Sirolimus Use Orbital Lymphatic Malformation Recruiting
NCT04789070 Phase III Trial of Sirolimus in IBM Inclusion Body Myositis Active, Not Recruiting
NCT07475546 Combination Gerotherapeutic Interventions for Healthspan Improvement Healthspan Improvement Active, Not Recruiting
NCT00679042 Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at… Type 1 Diabetes Mellitus Active, Not Recruiting
Phase 2/3
NCT07366801 Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell… Acute Myeloid Leukemia, Relapsed Recruiting
Phase 2
NCT05104983 Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study Tuberous Sclerosis Complex Recruiting
NCT03121001 Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive… Sickle Cell Disease Recruiting
NCT05237687 The Role of Sirolimus in Preventing Functional Decline in Older Adults Aging Recruiting
NCT04469530 Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid… Solid Tumor Recruiting
NCT04861064 Weekly Sirolimus Therapy Venous Malformation Recruiting
NCT03970096 Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… Acute Leukemia Recruiting
NCT04141020 Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms Cerebral Aneurysm Recruiting
NCT06261060 Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial… Familial Platelet Disorder Recruiting
NCT03214354 Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major… Sickle Cell Disease Recruiting
NCT04888741 Methods of T Cell Depletion Trial (MoTD) Acute Myeloid Leukemia Recruiting
NCT02042326 Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of… Arteriovenous Malformations Recruiting
NCT06055608 Advancing Transplantation Outcomes in Children Kidney Transplant Recruiting
NCT03243019 Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations Lymphatic Malformation Recruiting
NCT06872333 Allo HSCT for High Risk Hemoglobinopathies Graft Failure Recruiting
NCT05836025 Effect of Rapamycin in Ovarian Aging Perimenopausal Active, Not Recruiting
NCT03292861 The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients Heart Transplantation Enrolling by Invitation
NCT02979873 Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia… Severe Aplastic Anemia Active, Not Recruiting
Sponsors Running Sirolimus Trials
Disease Areas
Get alerts when Sirolimus trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free